Derzeitiger Therapiestandard beim pT1G3-Urothelkarzinom der Harnblase

Weichert-Jacobsen and Stöckle (1997) Radical cystectomy — often too late? In: Bohle, Joeham (eds). Optimal therapy for patients with high-risk superficial bladder cancer — controversy and consensus (MEDICINE Publishing Foundation Sieries 37) The Medicine Group (Education), Oxford, pp 37–44Google Scholar

Neal (1997) Pathological aspects of pT1G3 urothelial carcinoma and carcinoma in situ. In: Böhle, Jocham (eds). Optimal therapy for patients with high-risk superficial bladder cancer — controversy and consensus. (MEDICINE Publishing Foundation Sieries 37) The Medicine Group (Education), Oxford, pp 1–10Google Scholar

Kurth, Denis, Bouffioux, Sylvester, Debruyne, Pavone-Macaluso and Oosterlink (1995) Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 31A: 1840–1846PubMedCrossRefGoogle Scholar

Witjes, Kiemeney, Schaafsma, Debruyne and the members of the Dutch South East Cooperative Urological Group (1994) The influence of review pathology on study outcome of randomized multicentre superficial cancer trial. BrJ Urol 73: 172–176CrossRefGoogle Scholar

Herr, Badalament, Amato, Landane, Fair, Whitmore (1989) Superficial bladder cancer treated with BCG: a multivariate analysis of factors affecting tumour progression. J Urol 141: 22–28PubMedGoogle Scholar

Stöckle, Alken, Engelmann, Jacobi, Riedmiller, Hohenfellner (1987) Radical cystectomy — often too late? Eur Urol 13: 361–367PubMedGoogle Scholar

Whitmore (1982) Editorial comment. J Urol 128: 136Google Scholar

Kurth (1997) Diagnosis and treatment of superficial transitional cell carcinoma of the bladder: facts and perspectives. Eur Urol 31 [Suppl 1]:10–19PubMedGoogle Scholar

Oosterlink, Kurth, Schröder, Bultink, Hammond, Sylvester and Members of the EORTC GU group (1993) A prospective EORTC GU group randomized trial comparing transurethral resection followed by single intravesical instillation of epirubicin or water in single stage Ta/T1 papillary carcinoma of the bladder. J Urol 149: 749–752Google Scholar

Kurth (1996) Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how? Semin Urol Oncol 14 [Suppl 1]: 30–35PubMedGoogle Scholar